Terns Pharmaceuticals Inc (NASDAQ:TERN) shares, rose in value, with the stock price down by -8.50% to the previous day’s close as strong demand from buyers drove the stock to $5.49.
Actively observing the price movement in the last trading, the stock closed the session at $6.00. The value of beta (5-year monthly) was -0.62. Referring to stock’s 52-week performance, its high was $14.04, and the low was $3.26. On the whole, TERN has fluctuated by -24.69% over the past month.
With the market capitalization of Terns Pharmaceuticals Inc currently standing at about $354.93 million, investors are eagerly awaiting this quarter’s results, scheduled for May 13, 2024 – May 17, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.34, which is expected to increase to -$0.3 for fiscal year -$1.38 and then to about -$1.42 by fiscal year 2025. Data indicates that the EPS growth is expected to be -8.70% in 2025, while the next year’s EPS growth is forecast to be -2.90%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were 1 upward and no downward review(s) in last seven days. We see that TERN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TERN currently trading nearly -19.55% and -17.79% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.96, while the 7-day volatility ratio is showing 10.44% which for the 30-day chart, stands at 9.88%. Furthermore, Terns Pharmaceuticals Inc (TERN)’s beta value is -0.63, and its average true range (ATR) is 0.63.
A comparison of Terns Pharmaceuticals Inc (TERN) with its peers suggests the former has fared considerably weaker in the market. TERN showed an intraday change of -8.50% in last session, and over the past year, it shrunk by -52.75%%.
Data on historical trading for Terns Pharmaceuticals Inc (NASDAQ:TERN) indicates that the trading volumes over the past 10 days have averaged 1.02 million and over the past 3 months, they’ve averaged 887.82K. According to company’s latest data on outstanding shares, there are 64.58 million shares outstanding.
Nearly 38.75% of Terns Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 76.32% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.23 million shares as on Mar 15, 2024, resulting in a short ratio of 3.67. According to the data, the short interest in Terns Pharmaceuticals Inc (TERN) stood at 6.54% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 4.36 million. The stock has fallen by -15.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TERN stock heading into the next quarter.
